Seminars in Hematology
Volume 44, Supplement 4 , Pages S27-S31, July 2007

Overcoming Rituximab Resistance: The US Clinical Experience With Bendamustine

  • Jonathan W. Friedberg

      Affiliations

    • Corresponding Author InformationAddress correspondence to Jonathan W. Friedberg, MD, Associate Professor of Medicine, University of Rochester, Director, Hematological Malignancy Clinical Research, James P. Wilmot Cancer Center, 601 Elmwood Ave, Box 704, Room 1-4118C, Rochester, NY 14642.

Department of Medicine, Hematological Malignancy Clinical Research, James P. Wilmot Cancer Center, University of Rochester, Rochester, NY.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0037-1963(07)00093-5

doi:10.1053/j.seminhematol.2007.06.002

Seminars in Hematology
Volume 44, Supplement 4 , Pages S27-S31, July 2007

Article Tools

* Image Usage & Resolution